JMS Co

JMS Co Current Assets

The Current Assets of JMS Co (7702.T) as of Nov 2, 2026 is 28.74 B JPY. In the previous year, Current Assets was 45.77 B JPY — a change of -37.22% (lower).

Current Assets

28.74 BJPY

YoY

-37.22%

Last updated:

Current Assets of JMS Co is 2026 28.74 B JPY. Current Assets of JMS Co was 2025 45.77 B JPY. It decreases by -37.22% lower compared to the previous year.

The JMS Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
37.75 B JPY
Jan 1, 2020
37.09 B JPY
Jan 1, 2021
38.98 B JPY
Jan 1, 2022
40.04 B JPY
Jan 1, 2023
42.26 B JPY
Jan 1, 2024
48.67 B JPY
Jan 1, 2025
45.77 B JPY
Jan 1, 2026
28.74 B JPY
The JMS Co Current Assets history
YEARCurrent AssetsYoY
28.74 BJPY-37.22%
45.77 BJPY-5.94%
48.67 BJPY+15.15%
42.26 BJPY+5.55%
40.04 BJPY+2.72%
38.98 BJPY+5.11%
37.09 BJPY-1.75%
37.75 BJPY+0.40%
37.60 BJPY+3.63%
36.28 BJPY+3.05%
35.21 BJPY+2.25%
34.43 BJPY+11.91%
30.77 BJPY-0.90%
31.04 BJPY+8.68%
28.56 BJPY+3.22%
27.67 BJPY+3.82%
26.66 BJPY+5.88%
25.18 BJPY-1.94%
25.68 BJPY-0.70%
25.86 BJPY-1.04%
26.13 BJPY+0.18%
26.08 BJPY+16.65%
22.36 BJPY+0.64%
22.22 BJPY+24.31%
17.87 BJPY+8.51%
16.47 BJPY-14.25%
19.21 BJPY-20.12%
24.04 BJPY-4.24%
25.11 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Current Assets of JMS Co is 28.74 B JPY in 2026.

Current Assets of JMS Co changed from 45.77 B JPY to 28.74 B JPY, representing a -37.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets JMS Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JMS Co

All Key Metrics — JMS Co